Clinical Studies

No. Diagnosis Title Author(s) Year Medication(s) Design Major Outcome(s)
101 - Smoking and Diabetes Mellitus: Results from Meta-analysis with Eight Independent Replication Samples Alshaarawy O,
Anthony JC
2015 Cannabis Survey Cannabis use was associated with a 30% reduction of diabetes risk
102 Posttraumatic stress disorder The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study. Boisvert D,
Fraser G,
Heber A,
Jetly R
2015 Nabilone Controlled Study Nabilone reduced nightmares.
103 - Neural Effects of Cannabinoid CB1 Neutral Antagonist Tetrahydrocannabivarin on Food Reward and Aversion in Healthy Volunteers. Cowen PJ,
McCabe C,
Tudge L,
Williams C
2015 Other cannabinoids Controlled Study The natural cannabinoid tetrahydrocannabivarin (THCV) altered the nerve response to pleasant and unpleasant stimuli in a way that it “suggests therapeutic activity in obesity.
104 - Profiles of medicinal cannabis patients attending compassion centers in rhode island. Frater S,
Lally M,
Topletz A,
Yates G,
Zaller N
2015 Cannabis Survey Most participants report that medicinal cannabis improves their pain symptomology.
105 Pain Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy Atkinson JH,
Gonuaux B,
Marcotte TD,
Umlauf A,
Wallace MS
2015 Cannabis Controlled Study Inhaled cannabis demonstrated a dose dependent reduction in peripheral treatment-refractory neuropathic pain.
106 Epilepsy Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy Chapman KE,
Knupp KG,
Press CA
2015 Cannabis Open Study About one third of children suffering from different forms of epilepsy experienced a more than 50 % reduction in seizures by the use of oral cannabis extracts.
107 Dependency/withdrawal Safety of oral dronabinol during opioid withdrawal in humans Babalonis S,
Elayi SC,
Jicha CJ,
Lofwall MR,
Nuzzo PA,
Walsh SL
2015 Delta-9-THC Controlled Study 40 mg of THC caused increased heart rate and anxiety, which made dose-reduction necessary